Anti-natamycin monoclonal antibody hybridoma cell strain and application thereof
A hybridoma cell line and monoclonal antibody technology, applied in biochemical equipment and methods, instruments, microorganisms, etc., can solve the problems of expensive instruments, time-consuming, and relatively high requirements for experimental conditions, and achieve good detection sensitivity and specificity Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Example 1: Preparation of hybridoma cell line M
[0021] 1. Antigen synthesis
[0022] Weigh 20 mg of natamycin and dissolve it in 3 mL of DMF; weigh 100 mg of BSA and dissolve it in 5 mL of PBS; add 50 μL of 25% glutaraldehyde solution drop by drop to the natamycin solution, and store it in the dark at room temperature Stir and activate for 30 min; add the activated natamycin dropwise to BSA, and stir and react at room temperature for 4 h in the dark. After the reaction, unreacted natamycin was removed by dialysis with 0.01M PBS for three days to obtain a conjugate of natamycin and BSA, which was characterized by ultraviolet light.
[0023] 2. mouse immunization
[0024] Healthy BALB / c mice aged 6-8 weeks were selected for immunization. Natamycin antigen was mixed and emulsified with an equal amount of Freund's adjuvant, and BALB / c mice were immunized by subcutaneous injection in the back. Complete Freund's adjuvant was used for the first immunization, followed by...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com